Cargando…

Genetics of Type 1 Diabetes: What's Next?

Detalles Bibliográficos
Autores principales:	Pociot, Flemming, Akolkar, Beena, Concannon, Patrick, Erlich, Henry A., Julier, Cécile, Morahan, Grant, Nierras, Concepcion R., Todd, John A., Rich, Stephen S., Nerup, Jørn
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889752/ https://www.ncbi.nlm.nih.gov/pubmed/20587799 http://dx.doi.org/10.2337/db10-0076

Ejemplares similares

Genome-Wide Scan for Linkage to Type 1 Diabetes in 2,496 Multiplex Families From the Type 1 Diabetes Genetics Consortium
por: Concannon, Patrick, et al.
Publicado: (2009)

Tests for Genetic Interactions in Type 1 Diabetes: Linkage and Stratification Analyses of 4,422 Affected Sib-Pairs
por: Morahan, Grant, et al.
Publicado: (2011)

A Human Type 1 Diabetes Susceptibility Locus Maps to Chromosome 21q22.3
por: Concannon, Patrick, et al.
Publicado: (2008)

Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes
por: Barrett, Jeffrey C., et al.
Publicado: (2009)

Evidence of Gene-Gene Interaction and Age-at-Diagnosis Effects in Type 1 Diabetes
por: Howson, Joanna M.M., et al.
Publicado: (2012)

Confirmation of novel type 1 diabetes risk loci in families
por: Cooper, J. D., et al.
Publicado: (2012)

Design and Measurement of Nonislet-Specific Autoantibodies for the Type 1 Diabetes Genetics Consortium Autoantibody Workshop
por: Akolkar, Beena, et al.
Publicado: (2015)

Proteome Analysis—A Novel Approach to Understand the Pathogenesis of Type 1 Diabetes Mellitus
por: Karlsen, Allan E., et al.
Publicado: (2001)

Posttranslational Modifications of Proteins in Type 1 Diabetes: The Next Step in Finding the Cure?
por: Dunne, Jessica L., et al.
Publicado: (2012)

Low-grade inflammation in type 2 diabetes: a cross-sectional study from a Danish diabetes outpatient clinic
por: Okdahl, Tina, et al.
Publicado: (2022)

What's Next for Key and Core Tech?
por: Mi, Lei
Publicado: (2020)

Visual system repair: what’s next?
por: Vilallongue, Noemie, et al.
Publicado: (2021)

An Inflection Point in Cancer Protein Biomarkers: What was and What's Next
por: Barker, Anna D., et al.
Publicado: (2023)

Central Role for Interleukin-2 in Type 1 Diabetes
por: Hulme, Maigan A., et al.
Publicado: (2012)

Snakebite in the wake of COVID-19 – what’s next?
por: Moos, Bethany
Publicado: (2020)

Molecules, Information and the Origin of Life: What Is Next?
por: Chirumbolo, Salvatore, et al.
Publicado: (2021)

Type 1 Diabetes Prevention: A Goal Dependent on Accepting a Diagnosis of an Asymptomatic Disease
por: Ziegler, Anette-G., et al.
Publicado: (2016)

Danish children born with glutamic acid decarboxylase-65 and islet antigen-2 autoantibodies at birth had an increased risk to develop type 1 diabetes
por: Eising, Stefanie, et al.
Publicado: (2011)

125 years of the Wertheim operation. What next?
por: Drouin, Emmanuel, et al.
Publicado: (2023)

“Long COVID-19” of Researchers: What to Do Next?
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Summary of the Type 1 Diabetes Genetics Consortium Autoantibody Workshop
por: Rich, Stephen S., et al.
Publicado: (2015)

Role of Type 1 Diabetes–Associated SNPs on Autoantibody Positivity in the Type 1 Diabetes Genetics Consortium: Overview
por: Rich, Stephen S., et al.
Publicado: (2015)

SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes
por: Obukhov, Alexander G., et al.
Publicado: (2020)

Children at onset of type 1 diabetes show altered N-glycosylation of plasma proteins and IgG
por: Rudman, Najda, et al.
Publicado: (2022)

What’s next for WHO’s global strategy to reduce the harmful use of alcohol?
por: Jernigan, David H, et al.
Publicado: (2020)

Shared Genetic Basis for Type 1 Diabetes, Islet Autoantibodies, and Autoantibodies Associated With Other Immune-Mediated Diseases in Families With Type 1 Diabetes
por: Brorsson, Caroline A., et al.
Publicado: (2015)

Primer: Immunity and Autoimmunity
por: Pietropaolo, Massimo, et al.
Publicado: (2008)

Dilated eye examination screening guideline compliance among patients with diabetes without a diabetic retinopathy diagnosis: the role of geographic access
por: Lee, David J, et al.
Publicado: (2014)

The 2009 H1N1 Pandemic Influenza Virus: What Next?
por: Morens, David M., et al.
Publicado: (2010)

Malaria Epidemiology in Kilifi, Kenya during the 21st Century: What Next?
por: von Seidlein, Lorenz, et al.
Publicado: (2016)

Diabetes incidence and glucose intolerance prevalence increase with higher outdoor temperature
por: Blauw, Lisanne L, et al.
Publicado: (2017)

Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30–50% of Filtered Glucose Load in Humans
por: Abdul-Ghani, Muhammad A., et al.
Publicado: (2013)

Neurophysiological Pathways to Obesity: Below Awareness and Beyond Individual Control
por: Cohen, Deborah A.
Publicado: (2008)

Health-Chair Reform: Your Chair: Comfortable but Deadly
por: Levine, James A.
Publicado: (2010)

Mitochondrial Stability in Diabetic Retinopathy: Lessons Learned From Epigenetics
por: Kowluru, Renu A.
Publicado: (2019)

Historical Perspective: Beginnings of the β-Cell: Current Perspectives in β-Cell Development
por: Seymour, Philip A., et al.
Publicado: (2011)

Application of Isotopic Techniques Using Constant Specific Activity or Enrichment to the Study of Carbohydrate Metabolism
por: Vella, Adrian, et al.
Publicado: (2009)

The Streetlight Effect in Type 1 Diabetes
por: Battaglia, Manuela, et al.
Publicado: (2015)

The Paradox of Progress: Environmental Disruption of Metabolism and the Diabetes Epidemic
por: Neel, Brian A., et al.
Publicado: (2011)

Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function?
por: Meier, Juris J., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6tfcm9ne2kbso7kl98fggjg0bb